{"id":584,"date":"2026-09-21T09:42:00","date_gmt":"2026-09-21T09:42:00","guid":{"rendered":"https:\/\/andyguy.com\/?p=584"},"modified":"2026-09-21T02:53:58","modified_gmt":"2026-09-21T02:53:58","slug":"astera-labs-alab-earnings-quality-financial-analysis-price-target","status":"publish","type":"post","link":"https:\/\/andyguy.com\/en\/astera-labs-alab-earnings-quality-financial-analysis-price-target\/","title":{"rendered":"Astera Labs (ALAB) Net Income +1,991 TP3T, One-Third of That Was Tax Refunds \u2014 Financial Review and Target Price"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Over the weekend, I opened Astera Labs&#039; Q2 filing and created a table by placing the income statement and cash flow statement side by side. Revenue increased by 1,041 TP3T compared to a year ago, but the three lines for taxes, margins, and working capital all moved in the opposite direction. My conclusion is Sell, and my 12-month baseline target price is $238 (approximately 329,963 KRW). Let me break down the numbers to explain why I took this view.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The figures are based on the US market close on September 18. The KRW was set to 1,386.4 KRW per dollar on the same day, and all KRW amounts in the text were calculated using this exchange rate.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"#what-they-sell\">How does Astera Labs (ALAB) make money?<\/a><\/li>\n<li><a href=\"#earnings-quality\">Q2 Earnings Quality \u2014 The Reality of Net Income +199%<\/a><\/li>\n<li><a href=\"#quarterly-trend\">Sales and margin trends over the past 5 quarters<\/a><\/li>\n<li><a href=\"#cash-flow\">Where did the cash go?<\/a><\/li>\n<li><a href=\"#valuation\">Astera Labs (ALAB) Valuation and Competitor Comparison<\/a><\/li>\n<li><a href=\"#price-target\">Astera Labs (ALAB) Target Price Scenario<\/a><\/li>\n<li><a href=\"#risks\">Astera Labs (ALAB) Risks and Bear Triggers<\/a><\/li>\n<li><a href=\"#author-view\">The thoughts I changed from my June post<\/a><\/li>\n<li><a href=\"#conclusion\">Astera Labs (ALAB) Investment Opinion Conclusion<\/a><\/li>\n<li><a href=\"#faq\">Frequently Asked Questions<\/a><\/li>\n<li><a href=\"#sources\">source<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">For those who are busy, I will leave the three-line conclusion first.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>one.<\/strong> Revenue of $392.4 million in the second quarter of 2026 increased by 104.51 TP3T from a year ago, and guidance for the third quarter is +401 TP3T from the previous quarter, with no signs of slowing growth yet.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>two.<\/strong> However, one-third of the net profit of $153.09 million is a one-time corporate tax refund, and stock compensation expenses take back $67.21 million of the quarterly free cash flow.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>three.<\/strong> Based on 12-month projected earnings, 51 times is 21.41 TP3T higher than the fair multiple of 42 times that I determined, so I have closed with a 12-month baseline target of $238 (approx. 329,963 KRW) and a Sell rating.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-they-sell\">How does Astera Labs (ALAB) make money?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Astera Labs is a company that manufactures components connecting chips and servers within AI servers. No matter how fast a GPU is, it is useless if the data path is narrow. This company makes money by placing signal amplifiers (retarders), cable modules, memory controllers, and fabric switches that bundle multiple chips together in that pathway.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To use a highway analogy, it is not a company that manufactures cars, but one that makes interchanges and traffic lights. Just as interchanges get congested first as the number of cars increases, this company&#039;s components grow in tandem with the increase in AI servers. In fact <a href=\"https:\/\/andyguy.com\/en\/nvidia-nvda-q2-fy2027-earnings-cash-flow-analysis\/\">NVIDIA (NVDA) quarterly revenue increased by 1,061 TP3T in one year<\/a>And this company&#039;s sales curve moves in almost the same shape.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Revenue for the second quarter of 2026 was $392.4 million (approximately 544 billion KRW), an increase of 104.51 TP3T from a year ago and 27.31 TP3T from the previous quarter. The guidance for the third quarter is between $540 million and $560 million. A median value of $550 million (approximately 762.5 billion KRW) means it is 401 TP3T larger than the previous quarter. Far from slowing down, the growth rate has actually accelerated.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"earnings-quality\">Q2 Earnings Quality \u2014 The Reality of Net Income +199%<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Looking only at the headline, it seems perfect. Q2 GAAP net income was $153.09 million (approximately 212.2 billion KRW), an increase of 198.91 TP3T from a year ago. However, I changed my mind after looking at the three lines below. The table below is the three-step staircase of earnings quality that I created.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>step<\/th><th>amount<\/th><th>Korean Won Conversion<\/th><th>What does it mean?<\/th><\/tr><\/thead><tbody><tr><td>\u2460 Announced GAAP Net Income<\/td><td>$153.09 million<\/td><td>Approximately 212.2 billion won<\/td><td>$0.83 per share (approx. 1,151 won)<\/td><\/tr><tr><td>\u2461 Pre-tax profit<\/td><td>$102.83 million<\/td><td>Approximately 142.6 billion won<\/td><td>Actual operating performance before tax<\/td><\/tr><tr><td>\u2462 Corporate tax refund<\/td><td>+$50.26 million<\/td><td>Approximately 69.7 billion won<\/td><td>I didn&#039;t pay taxes, I got them back.<\/td><\/tr><tr><td>\u2463 Net profit assuming a tax rate of 15%<\/td><td>Approximately $87.4 million<\/td><td>Approximately 121.2 billion won<\/td><td>About $0.48 per share<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">You can read this table from top to bottom. If you subtract the tax effect from the announced net profit, you can see the company&#039;s actual financial strength. Of the $153.09 million in net profit, $50.26 million\u2014or about one-third\u2014is generated from tax refunds. This means that the money was not earned by selling more products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If I recalculate assuming a standard effective tax rate of 151 TP3T, net income comes down to approximately $87.4 million, or about $0.48 per share. This corresponds to the announced figure of 581 TP3T. Since tax refunds are not a recurring item, it is difficult to assume that the same amount will be received next year. Therefore, I did not include the phrase \u201cNet Income +1991 TP3T\u201d in the valuation as is.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"quarterly-trend\">Sales and margin trends over the past 5 quarters<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">My judgment was wavering when looking at just one quarter, so I put five quarters together. The point where the revenue curve and the margin curve diverge in different directions catches my eye.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>branch<\/th><th>sales<\/th><th>Compared to the previous quarter<\/th><th>Gross profit margin<\/th><th>Operating profit margin<\/th><\/tr><\/thead><tbody><tr><td>Q2 2025<\/td><td>$191.93 million<\/td><td>\u2014<\/td><td>75.8%<\/td><td>20.7%<\/td><\/tr><tr><td>Q3 2025<\/td><td>$230.58 million<\/td><td>+20.1%<\/td><td>76.3%<\/td><td>24.0%<\/td><\/tr><tr><td>Q4 2025<\/td><td>$270.58 million<\/td><td>+17.4%<\/td><td>75.6%<\/td><td>24.7%<\/td><\/tr><tr><td>Q1 2026<\/td><td>$308.36 million<\/td><td>+14.0%<\/td><td>76.3%<\/td><td>20.1%<\/td><\/tr><tr><td>Q2 2026<\/td><td>$392.4 million<\/td><td>+27.3%<\/td><td>73.3%<\/td><td>22.7%<\/td><\/tr><tr><td>Q3 2026 (Guidance)<\/td><td>About $550 million<\/td><td>+40.2%<\/td><td>Approx. 72% (non-GAAP)<\/td><td>Approx. 43% (non-GAAP)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The gross profit margin is the profit ratio calculated by subtracting the cost of goods sold from every 100 won in sales. A ratio of 73.31 TP3T means that for every 100 won worth of sales, 73.3 won remains after deducting the cost of goods sold (26.7 won). In the context of a neighborhood bakery, this is a very good business, as the cost of ingredients is only 27 won. However, the key point is that this ratio dropped by 2.51 TP3T points from 75.81 TP3T a year ago to 73.31 TP3T, and the company itself stated that it would be around 721 TP3T in the third quarter.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The reason is that the product lineup is changing. The Scorpio X series fabric switches and cable modules, which have seen a surge in demand, have a higher proportion of component costs than pure semiconductor chips. The phenomenon where the average profit margin decreases as sales increase is called margin dilution. It is a structure where, just as sales growth is welcome, the profit margin is being cut down by every single unit.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You also need to look at R&amp;D expenses. Second-quarter R&amp;D expenses amounted to $135.9 million (approximately 188.4 billion KRW), representing 34.61 TP3T of revenue. This is an increase of 103.71 TP3T compared to a year ago, which is almost the same rate as revenue growth. Since the structure is such that R&amp;D expenses double when revenue doubles, cost efficiency does not automatically improve simply because the scale increases.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"cash-flow\">Where did the cash go?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Cash flow from operating activities in the second quarter was $87.68 million, and free cash flow (FCF), remaining after deducting $20.47 million in capital expenditures, was $67.21 million (approximately 93.2 billion won). Free cash flow is the actual cash remaining in hand after deducting capital expenditures from earnings. Compared to the net profit of $153.09 million, this is less than half.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The first item that made a difference is working capital. In the second quarter alone, $142.46 million (approximately 197.5 billion won) was tied up in working capital. This is because accounts receivable increased by $57.67 million (approximately 80 billion won), inventory by $53.47 million (approximately 74.1 billion won), and prepayments by $55.31 million. Working capital is money that goes out first as business gets better. It is akin to buying more materials because the number of customers increases, causing the credit ledger to get longer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The second item is what I looked at most closely. Stock compensation expenses for the second quarter (compensation paid to employees in company stock instead of cash) amounted to $63.99 million (approximately 88.7 billion won). This is 951 TP3T, compared to the free cash flow of $67.21 million in the same quarter. Since this is an accounting expense that does not involve cash outflow, it is not reflected in free cash flow; however, it increases the number of shares, thereby diluting the share for existing shareholders.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Even if we expand the scope to the last four quarters, the picture remains the same. The total free cash flow is $276.68 million (approximately 383.6 billion won), while the total stock compensation expenses are $195.02 million (approximately 270.4 billion won). If we recognize stock compensation expenses as costs and subtract them, the remaining cash decreases to $81.66 million. This means that this is the actual net cash accumulated over a year by a company with a market capitalization of $52.6 billion (approximately 72.9 trillion won).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The balance sheet itself is very clean. Cash and short-term investments combined amount to $1.25296 billion, and total borrowings are only $44.41 million, resulting in net cash of $1.20855 billion (approximately 1.68 trillion won). The current ratio is also 10.05 times, which means that for every 1 won of debt due within one year, there are 10 won in immediately usable assets. This is not a company that needs to worry about going bankrupt. What I am taking issue with is not safety, but the quality and price of earnings.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"valuation\">Astera Labs (ALAB) Valuation and Competitor Comparison<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">First, we need to determine the projected earnings per share (EPS) for the next 12 months. Earnings per share is calculated by dividing a company&#039;s net profit by the number of shares outstanding\u2014in other words, the money earned by one share. If we combine the Q3 non-GAAP guidance of $1.16 to $1.21 (median value of approximately 1,643 KRW) with the market consensus (average of analyst forecasts), the non-GAAP earnings per share for the next 12 months is calculated to be approximately $5.95 (approximately 8,249 KRW).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If we divide the current share price of $303.25 (approximately 420,426 KRW) by this, the forward price-to-earnings (P\/E) ratio is about 51 times. This means that it would take 51 years for current projected earnings to accumulate to match the share price. The question is, &quot;Is 51 times a reasonable value?&quot; I did not use the current multiple as is, but instead combined two criteria to determine an appropriate multiple.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">One is the average forward P\/E of approximately 52x since the company&#039;s IPO in March 2024, and the other is the industry median of approximately 26.7x. Mixing the two in equal parts yields 39.4x, and applying 7% to reflect that the revenue growth rate and gross profit margin are clearly higher than the industry average, <strong>Optimal multiplier 42 times<\/strong>I decided on that. Currently, 51x is an expensive position here at 21.41 TP3T.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>event<\/th><th>The current price<\/th><th>Market capitalization<\/th><th>Preceding P\/E<\/th><th>TTM P\/S<\/th><th>Sales growth rate<\/th><th>Gross profit margin<\/th><\/tr><\/thead><tbody><tr><td>Astera Labs (ALAB)<\/td><td>$303.25<\/td><td>$52.6 billion<\/td><td>About 51.0 times<\/td><td>43.8 times<\/td><td>+104.5%<\/td><td>73.3%<\/td><\/tr><tr><td>CRDO<\/td><td>$175.89<\/td><td>$33.1 billion<\/td><td>18.1 times<\/td><td>20.8 times<\/td><td>+114.7%<\/td><td>67.1%<\/td><\/tr><tr><td>Marvel (MRVL)<\/td><td>$244.25<\/td><td>$219.5 billion<\/td><td>36.1 times<\/td><td>23.2 times<\/td><td>+36.5%<\/td><td>52.2%<\/td><\/tr><tr><td>Broadcom (AVGO)<\/td><td>$357.61<\/td><td>$1.7071 trillion<\/td><td>18.5 times<\/td><td>19.2 times<\/td><td>+85.5%<\/td><td>75.5%<\/td><\/tr><tr><td>Monolithic Power (MPWR)<\/td><td>$1,217.80<\/td><td>$59.8 billion<\/td><td>34.9 times<\/td><td>18.3 times<\/td><td>+47.6%<\/td><td>55.2%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">This table is easier to read if you look at the two columns on the far right (growth rate and profit margin) first, and then move your eyes to the multiple columns on the left. Since the fiscal year closing times differ for each company, the base periods for forward P\/E are not exactly the same, so please look at the order rather than the absolute values. Credo stands out. Its revenue growth rate is 114.71 TP3T, which is higher than Astera Labs, yet its forward P\/E is 18.1 times. <a href=\"https:\/\/andyguy.com\/en\/broadcom-avgo-q3-fy2026-earnings-review-price-target\/\">Broadcom (AVGO) that I organized a while ago<\/a>The gross profit margin is 18.5 times 75.5%.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It is similar when looking at the price-to-sales ratio (P\/S). Astera Labs is at 43.8 times, while the median for the top four companies is 20.0 times. Even when converted to a forward P\/S based on projected 2027 revenue of $2.95 billion (approximately 4.09 trillion won), it stands at 17.8 times, which is 521 TP3T higher than the peer median of 11.7 times. <a href=\"https:\/\/andyguy.com\/en\/macom-mtsi-stock-analysis-target-price-2026\/\">The forward P\/E of 36x summarized in the McCombs (MTSI) post<\/a>It is definitely superior even when compared to...<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I also ran a DCF, which converts future cash into today&#039;s value and adds them together. DCF is a &quot;theoretical fair value&quot; calculation method that converts a company&#039;s future earnings into present-day money and combines them. In the base scenario, set with a Weighted Average Cost of Capital (WACC) of 11.01 TP3T, a terminal growth rate of 3.01 TP3T, and a 10-year forecast period, the result was $90 per share. In the bullish scenario, which uses a discount rate of 9.51 TP3T and a terminal growth rate of 3.51 TP3T with a more optimistic growth path, the result was $201. Since the beta was so high at 3.78, it was difficult to set a low discount rate.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"price-target\">Astera Labs (ALAB) Target Price Scenario<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The baseline target price was determined by combining multiple calculations and DCF at a 75:25 ratio. The multiple calculation resulted in $249.9, calculated by multiplying the estimated earnings per share of $5.95 by an appropriate multiple of 42x, while the DCF used the upper end of the bullish scenario at $201. The reason for the low weighting of DCF is that including a company growing by 401 TP3T every quarter in a 10-year cash flow model makes it easy to underestimate the initial curve. However, I retained one-quarter of the weight as a reality check mechanism.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><thead><tr><th>scenario<\/th><th>Target price<\/th><th>Korean Won Conversion<\/th><th>Compared to the current price<\/th><th>weight<\/th><th>Key assumptions<\/th><\/tr><\/thead><tbody><tr><td>Bull<\/td><td>$310<\/td><td>Approximately 429,784 won<\/td><td>+2.2%<\/td><td>25%<\/td><td>Raised EPS forecast to $6.50, maintained multiple at 47.7x<\/td><\/tr><tr><td>Base<\/td><td>$238<\/td><td>Approximately 329,963 won<\/td><td>-21.5%<\/td><td>45%<\/td><td>Estimated EPS $5.95 \u00d7 Fair multiple 42x, reflecting DCF 25%<\/td><\/tr><tr><td>Bear<\/td><td>$180<\/td><td>Approximately 249,552 won<\/td><td>-40.6%<\/td><td>30%<\/td><td>Missed EPS at $5.50, multiple reduced to 32.7x<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The weighted average of the three scenarios yields $238.6, with an expected return of -21.31 TP3T. Let me explain why I set the weights at 451 TP3T for the base, 251 TP3T for the bullish, and 301 TP3T for the bearish. Since a premium of 211 TP3T relative to the appropriate multiple does not indicate an extreme overvaluation zone, I did not raise the bearish weight above 351 TP3T. However, given the beta of 3.78 and the fact that it dropped 391 TP3T in just three months from its June high of $499.48 (approx. 692,474 KRW), I increased the bearish weight compared to the base value of 251 TP3T.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I will also disclose the growth assumptions. If we multiply the past two-year average annual revenue growth rate of approximately 951 TP3T by 401 TP3T, the consensus-based 2027 revenue growth rate of 551 TP3T by 401 TP3T, and the AI connectivity semiconductor industry growth rate of 351 TP3T by 201 TP3T, and add them together, the weighted growth rate becomes 671 TP3T. The key point of my judgment is that the target price falls below the current price even with this level of growth already assumed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"risks\">Astera Labs (ALAB) Risks and Bear Triggers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">I organized the risks in the following order: \u201cWhat is dangerous \u2192 How does it affect performance \u2192 What you need to look for.\u201d.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Margin dilution<\/strong> \u2192 As the proportion of switch and cable modules increases, the average gross profit margin decreases. \u2192 Check if the non-GAAP gross profit margin in the quarterly earnings data falls further below 72%.<\/li>\n<li><strong>Customer Focus<\/strong> \u2192 A small number of hyperscalers account for the majority of sales, so if one of them switches to in-house design, the entire volume is lost. \u2192 You can check if the number of \u201ccustomers with sales of 101 TP3 T or more\u201d decreases in the sales concentration notes of the quarterly report (10-Q). <a href=\"https:\/\/andyguy.com\/en\/arista-networks-anet-800g-order-flow-customer-concentration\/\">A case at Arista Networks (ANET) where two customers accounted for 421 TP3 T of revenue<\/a>It is a danger with the same nature.<\/li>\n<li><strong>Cash consumption of growth<\/strong> \u2192 As sales increase, inventory and accounts receivable grow first, tying up cash. \u2192 Look at the gap between quarterly free cash flow and stock compensation expenses, along with the inventory turnover days.<\/li>\n<li><strong>Valuation and Volatility<\/strong> With a beta of 3.78, if the market moves 11 TP3T, this stock moves an average of 3.81 TP3T. A single piece of news regarding AI capital expenditure fluctuates between 30 and 401 TP3T. \u2192 Check the quarterly capital expenditure guidance of major hyperscalers.<\/li>\n<li><strong>Intensified competition<\/strong> \u2192 Broadcom, Marvell, and Credo are entering the same PCIe\/Ethernet connectivity domain. \u2192 You can track the frequency of announcements regarding new customer design adoptions (design wins).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">I identify three signals of a bearish reversal. First, if the quarter-over-quarter growth rate in the Q4 guidance falls below 151 TP3T. Second, if the gross profit margin breaks the 701 TP3T mark. Third, if the 2027 consensus earnings per share of $6.39 shifts downward. If two of these occur simultaneously, my bearish scenario of $180 becomes a realistic value.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"author-view\">The thoughts I changed from my June post<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Before writing this post <a href=\"https:\/\/andyguy.com\/en\/astera-labs-alab-stock-analysis-2026\/\">The Astera Labs post I wrote on June 21st<\/a>I opened it up again. Back then, I had set the target price at $390 and the rating as &quot;Hold.&quot; To be honest, that $390 figure was essentially a direct reflection of the multiples the market was offering at the time. This time, I recalculated by combining the company&#039;s own average with the industry median, which brought the figure down to $238. It isn&#039;t that the company has deteriorated; I simply changed my calculation criteria. In the meantime, revenue actually exceeded my expectations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I didn&#039;t necessarily interpret the $53.47 million increase in inventory in one quarter as a bad sign. For a company that says it will increase sales by $401 TP3T in the next quarter, it makes sense to stockpile in advance. However, if sales in the fourth quarter don&#039;t keep up that much, this inventory will quickly turn into a margin issue. That is why I plan to look at inventory turnover days before sales in the next earnings report. In my view, this stock falls into the category of being a &quot;good company, but currently expensive,&quot; and the purpose of this post was to analyze those two factors separately.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"conclusion\">Astera Labs (ALAB) Investment Opinion Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">My opinion is <strong>Sell, confidence level is Medium<\/strong>The 12-month baseline target price is $238 (approximately 329,963 won).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">There are three reasons why I rated it as Sell. First, the current multiple of 51x is 21.41 TP3T expensive compared to the fair value of 42x, and the expected return is calculated at -21.31 TP3T. Second, one-third of the Q2 net profit was a corporate tax refund, and stock compensation expenses took back 951 TP3T of the free cash flow, so the company&#039;s actual strength is thinner than the reported earnings. Third, the gross profit margin has declined over three quarters, and the company itself projected 721 TP3T for Q3. Conversely, growth is clearly alive, which is why I rated my confidence level as Medium rather than High.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This differs from the Wall Street consensus. The average target price of 23 analysts is $389.95, with a median of $425, effectively a Buy recommendation. The only difference between me and them is the appropriate multiple. The market considers a forward multiple of 65 to 70 times to be normal, while I consider 42 times to be normal. I believe it is risky to use the short stock price history of a company that has been listed for only two and a half years as the &quot;historical average,&quot; so I incorporated the industry median for half of the data. If you do not agree with this, the conclusion will naturally be different.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To summarize, I suggest separating the company from the stock price. The business is highly likely to continue growing as AI servers expand. However, the current stock price already accounts for a significant portion of that growth, and the quality of earnings is thinner than the headlines suggest. I recommend reviewing the Q3 earnings report first to confirm the maintenance of the gross profit margin (721 TP3T) and inventory turnover days before making a final judgment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"faq\">Frequently Asked Questions<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">What is the target price for Astera Labs (ALAB)?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">My 12-month baseline target price is $238 (approximately 329,963 KRW), and my rating is Sell. I set the target at $310 for a bullish scenario and $180 for a bearish scenario. For reference, the average target price of 23 Wall Street analysts is $389.95, which is significantly higher than mine.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sales increased by 1,041 TP3T, so why is the recommendation for Sell?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Growth is actually good. The problem is the price. A multiple of 51 times earnings over the next 12 months is 21.41 TP3T more expensive than the fair multiple of 42 times that I calculated. On top of that, one-third of the net profit is a one-time corporate tax refund, and the gross profit margin has been declining for three consecutive quarters, so the expected rate of return came out negative.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">What is the biggest risk at Astera Labs right now?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">I view margin dilution and customer concentration as the most significant factors. As the proportion of switch and cable modules increases, the gross profit margin decreases, and since a small number of hyperscalers account for the majority of sales, the impact is significant even if just one of them switches to in-house design. You can look at the gross profit margin in the quarterly earnings report together with the customer concentration notes in the 10-Q.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"sources\">source<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/ir.asteralabs.com\/news-events\/news-releases\" rel=\"nofollow noopener\" target=\"_blank\">Astera Labs Investor Relations \u2014 Quarterly Earnings Press Release<\/a><\/li>\n<li><a href=\"https:\/\/www.sec.gov\/cgi-bin\/browse-edgar?action=getcompany&amp;CIK=ALAB&amp;type=10-Q&amp;dateb=&amp;owner=include&amp;count=40\" rel=\"nofollow noopener\" target=\"_blank\">U.S. Securities and Exchange Commission (SEC) EDGAR \u2014 Astera Labs 10-Q Original Text<\/a><\/li>\n<li><a href=\"https:\/\/seekingalpha.com\/news\/4625206-astera-labs-rises-as-q2-results-feature-104-revenue-jump\" rel=\"nofollow noopener\" target=\"_blank\">Seeking Alpha \u2014 Q2 2026 Earnings Summary<\/a><\/li>\n<li><a href=\"https:\/\/stockanalysis.com\/stocks\/alab\/forecast\/\" rel=\"nofollow noopener\" target=\"_blank\">stockanalysis.com \u2014 Analyst target price consensus<\/a><\/li>\n<li><a href=\"https:\/\/tradingeconomics.com\/south-korea\/currency\" rel=\"nofollow noopener\" target=\"_blank\">Trading Economics \u2014 KRW\/USD Exchange Rate (September 18, 2026)<\/a><\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">The draft of this article was created by organizing publicly available disclosures and market data using AI tools, and I personally verified the numbers and logic once more before publication. This is a compilation of information, not a recommendation to buy or sell specific stocks. Please remember that stock prices, exchange rates, and estimates reflect the values at the time of writing and may change later; the final judgment and its consequences are the investor&#039;s responsibility.<\/p>","protected":false},"excerpt":{"rendered":"<p>Astera Labs (ALAB) has a 12-month baseline target of $238 (approx. 329,963 KRW) and a Sell rating (Medium confidence). Revenue for Q2 2026 is $392.4 million, an increase of 104.51 TP3T year-over-year, and guidance for Q3 is also +401 TP3T from the previous quarter. However, one-third of the $153.09 million in net income is a one-time corporate tax refund, and stock compensation expenses take away 951 TP3T of the $67.21 million in quarterly free cash flow. Base exchange rate: 1 USD = 1,386.4 KRW (2026-09-18).<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[62,152],"tags":[174,50,5,175,55],"class_list":["post-584","post","type-post","status-publish","format-standard","hentry","category-ai-datacenter","category-us-stock-analysis","tag-alab","tag-50","tag-5","tag-astera-labs","tag-stock-analysis"],"_links":{"self":[{"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/posts\/584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/comments?post=584"}],"version-history":[{"count":1,"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/posts\/584\/revisions"}],"predecessor-version":[{"id":585,"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/posts\/584\/revisions\/585"}],"wp:attachment":[{"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/media?parent=584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/categories?post=584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/andyguy.com\/en\/wp-json\/wp\/v2\/tags?post=584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}